Does lung allocation score maximize survival benefit from lung transplantation?

Area of Science:

• Organ transplantation research
• Transplant recipient outcomes
• Medical urgency scoring systems

Background:

• The Lung Allocation Score (LAS) was implemented in May 2005 to prioritize lung transplant candidates based on medical urgency and predicted post-transplant survival.
• The precise relationship between LAS stratification and actual candidate outcomes, including survival benefit, requires further characterization.

Purpose of the Study:

• To describe patient outcomes stratified by their LAS at the time of listing for lung transplantation.
• To estimate the net survival benefit conferred by lung transplantation across different LAS strata.

Main Methods:

• Utilized de-identified patient data from the United Network for Organ Sharing (UNOS) for 6,082 lung transplant candidates listed between May 2005 and May 2009.
• Stratified candidates into seven LAS groups (LAS <40 to LAS 90+) and analyzed waiting list mortality and transplantation likelihood.
• Calculated net survival benefit as the difference between post-transplant graft survival and waiting list survival, accounting for death or censoring at transplant/last follow-up.

Main Results:

• Candidates in the lowest LAS strata (<40 and 40-49) had less than 4% mortality on the waiting list within 90 days.
• The highest median net survival benefits were observed in the mid-LAS groups: 50-59 (3.44 years), 60-69 (3.49 years), and 70-79 (2.81 years).
• The lowest net survival benefits were seen in the LAS <40 (-0.7 years) and LAS 90+ (1.95 years) groups.

Conclusions:

• Lung transplantation offers the greatest survival advantage for candidates in the mid-LAS priority groups (50-79).
• Low-priority candidates (majority of recipients) show less survival benefit due to low waiting list mortality.
• High-priority candidates (LAS 80-90+) have reduced net survival benefit despite shorter wait times, attributed to poorer post-transplant survival.